Newly Approved Front-Line cHL Treatment Was First in Over 40 Years
- Allen, P. B., & Gordon, L. I. (2017). Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors. Clinical Medicine Insights. Oncology, 11, 1179554917731072. http://doi.org/10.1177/1179554917731072
- Progression-free survival. National Cancer Institute. Available at https://www.cancer.gov/publications/dictionaries/cancer-terms/def/progression-free-survival. Accessed 4/16/18.
- FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm601935.htm
- Adcetris prescribing information. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125388s094lbl.pdf